2015
DOI: 10.3389/fbioe.2015.00135
|View full text |Cite
|
Sign up to set email alerts
|

Analytics for Metabolic Engineering

Abstract: Realizing the promise of metabolic engineering has been slowed by challenges related to moving beyond proof-of-concept examples to robust and economically viable systems. Key to advancing metabolic engineering beyond trial-and-error research is access to parts with well-defined performance metrics that can be readily applied in vastly different contexts with predictable effects. As the field now stands, research depends greatly on analytical tools that assay target molecules, transcripts, proteins, and metabol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
60
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
2
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(60 citation statements)
references
References 115 publications
(125 reference statements)
0
60
0
Order By: Relevance
“…S. cerevisiae is a widely used industrial workhorse for producing a broad spectrum of chemicals that represents over quarter trillion dollars market 38 . The experimental and analytical approaches described here raise the possibility of genome-scale reprogramming of metabolic fluxes, which will dramatically speed up the “design-build-test” cycle in industrial biomanufacturing 39 . We also expect our method could be used to rewire the fate of yeast cells, such as cell cycle, and thus generate new biological insights on the fundamentals of metabolic diseases, aging and apoptosis by using yeast as a disease model.…”
Section: Discussionmentioning
confidence: 99%
“…S. cerevisiae is a widely used industrial workhorse for producing a broad spectrum of chemicals that represents over quarter trillion dollars market 38 . The experimental and analytical approaches described here raise the possibility of genome-scale reprogramming of metabolic fluxes, which will dramatically speed up the “design-build-test” cycle in industrial biomanufacturing 39 . We also expect our method could be used to rewire the fate of yeast cells, such as cell cycle, and thus generate new biological insights on the fundamentals of metabolic diseases, aging and apoptosis by using yeast as a disease model.…”
Section: Discussionmentioning
confidence: 99%
“…The implemented pathways typically need to be optimized further for economically viable production titers and rates. The optimization is performed through the Design-Built-Test-(Learn) cycle of metabolic engineering [56][57][58] where stoichiometric [59][60][61] and kinetic models [62][63][64][65][66][67][68][69] , genome editing 70,71 and phenotypic characterization 72 are combined to improve recombinant strains for production of biochemicals.…”
Section: Further Experimental Implementation and Pathway Optimizationmentioning
confidence: 99%
“…The highest ranked candidate pathways can then be experimentally implemented in the host organism and can further be optimized through the Design-Built-Test-(Learn) cycle of metabolic engineering. [56][57][58]…”
Section: Experimental Implementation and Pathway Optimizationmentioning
confidence: 99%
“…Still, the examples are all for titres that are well below industrially relevant ones, and it remains to be seen if the dynamic range of these biosensor systems can be stretched to be applied to select for improved strains at those high product concentrations. It is to be expected that the advances in microfluidics and microdroplet technologies will open up new avenues of high-throughput strain selection, including advanced mass spectrometry analytics and single-cell transcriptomics (Petzold et al, 2015;Kou et al, 2016).…”
Section: Testmentioning
confidence: 99%